Two longitudinal serum sampling in all HCW from the WELCOME cohort allowed careful monitoring of seroconversion against the RBD-S1 protein, pre- and post - prime/boost and third COVID 19 vaccine, as shown Fig. 1A as well as collection of intercurrent breakthrough infections. This evidence concerns the gene PSMD1 and infection.